Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)

DOI PDF Web Site Web Site 3 Citations

Journal

Annals of Oncology

Annals of Oncology 24 (4), 993-999, 2013-04

Elsevier BV

Citations (3)*help

See more

Details 詳細情報について

CRID

1360574094769986688
DOI

10.1093/annonc/mds529
ISSN

09237534
Web Site

https://api.elsevier.com/content/article/PII:S0923753419371753?httpAccept=text/xml

https://api.elsevier.com/content/article/PII:S0923753419371753?httpAccept=text/plain

http://academic.oup.com/annonc/article-pdf/24/4/993/716547/mds529.pdf
Data Source
- Crossref

Export

Report a problem

Back to top